Episode Details

In his weekly clinical update, Dr. Griffin discusses the CDC vaccine advisory group recommending the newly approved RSV vaccines, association of culturable-virus detection and household transmission of SARS-CoV-2, prevention of COVID-19 following a single intramuscular administration of Adintrevimab, real-world effectiveness of Nirmatrelvir/Ritonavir on COVID-19, and COVID-19 convalescent plasma outpatient therapy to prevent outpatient hospitalization.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• CDC vaccine advisory group recommends RSV vaccines
• Association of culturable-virus detection and household transmission of SARS-CoV-2 (JID)
• Prevention of COVID-19 following intramuscular administration of Adintrevimab (OFID)
• Real-world effectiveness of Nirmatrelvir/Ritonavir on COVID-19 (CID)
• COVID-19 convalescent plasma outpatient therapy to prevent hospitalization (CID)
• Contribute to our FIMRC fundraiser at PWB
• Letters read on TWiV 1018
• Dr. Griffin’s COVID treatment summary (pdf)
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv